{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T17:26:57Z","timestamp":1787160417159,"version":"build-2736575974"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In a retrospective single-center cohort study of 460 children with Kawasaki Disease, initial treatment with low-dose aspirin and intravenous immunoglobulin (IVIG) resulted in similar coronary artery outcomes and IVIG retreatment rates compared to high-dose aspirin and IVIG. These findings support consideration of low-dose aspirin for the management of acute-phase Kawasaki Disease.<\/jats:p>","DOI":"10.1093\/jpids\/piag002","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:28:17Z","timestamp":1768307297000},"source":"Crossref","is-referenced-by-count":1,"title":["Lack of Discernible Benefit of High-Dose Aspirin in the Treatment of Kawasaki Disease"],"prefix":"10.1093","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5061-945X","authenticated-orcid":false,"given":"Lavina","family":"Thadani","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Feinberg School of Medicine Northwestern University , Chicago, IL ,","place":["United States"]},{"name":"School of Medicine, University of Missouri-Kansas City , Kansas City, MO ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huthaifah","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Feinberg School of Medicine Northwestern University , Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4168-757X","authenticated-orcid":false,"given":"Kwang-Youn","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University , Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanford","family":"Shulman","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Feinberg School of Medicine Northwestern University , Chicago, IL ,","place":["United States"]},{"name":"Department of Pediatrics, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago , Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rowley","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Feinberg School of Medicine Northwestern University , Chicago, IL ,","place":["United States"]},{"name":"Department of Pediatrics, Ann & Robert H. Lurie Children\u2019s Hospital of Chicago , Chicago, IL ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026020409520856600_ref1","doi-asserted-by":"publisher","first-page":"e003289","DOI":"10.1161\/JAHA.116.003289","article-title":"Coronary artery aneurysms in Kawasaki disease: risk factors for progressive disease and adverse cardiac events in the US population","volume":"5","author":"Friedman","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"2026020409520856600_ref2","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000145143.19711.78","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease","volume":"110","author":"Newburger","year":"2004","journal-title":"Circulation."},{"key":"2026020409520856600_ref3","doi-asserted-by":"publisher","first-page":"e481","DOI":"10.1161\/CIR.0000000000001295","article-title":"Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association","volume":"150","author":"Jone","year":"2024","journal-title":"Circulation."},{"key":"2026020409520856600_ref4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/S0022-3476(96)80140-5","article-title":"Gastrointestinal hemorrhage complicating aspirin therapy in acute Kawasaki disease","volume":"128","author":"Matsubara","year":"1996","journal-title":"J Pediatr"},{"key":"2026020409520856600_ref5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.1988.03410050077033","article-title":"Reye\u2019s syndrome and aspirin. Evidence for a dose-response effect","volume":"260","author":"Pinsky","year":"1988","journal-title":"JAMA."},{"key":"2026020409520856600_ref6","doi-asserted-by":"publisher","first-page":"e20170098","DOI":"10.1542\/peds.2017-0098","article-title":"Aspirin dose and prevention of coronary abnormalities in Kawasaki disease","volume":"139","author":"Dallaire","year":"2017","journal-title":"Pediatrics."},{"key":"2026020409520856600_ref7","doi-asserted-by":"publisher","first-page":"e0217274","DOI":"10.1371\/journal.pone.0217274","article-title":"Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: current evidence based on a meta-analysis","volume":"14","author":"Zheng","year":"2019","journal-title":"PLoS One"},{"key":"2026020409520856600_ref8","doi-asserted-by":"publisher","first-page":"146","DOI":"10.4103\/apc.APC_206_20","article-title":"Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm","volume":"14","author":"Sanati","year":"2021","journal-title":"Ann Pediatr Cardiol"},{"key":"2026020409520856600_ref9","first-page":"209","article-title":"High-dose aspirin for Kawasaki disease: outdated myth or effective aid?","volume":"35 Suppl 103","author":"Amarilyo","year":"2017","journal-title":"Clin Exp Rheumatol"},{"key":"2026020409520856600_ref10","doi-asserted-by":"publisher","first-page":"e1918565","DOI":"10.1001\/jamanetworkopen.2019.18565","article-title":"Comparison of risk of recrudescent fever in children with Kawasaki disease treated with intravenous Gammaglobulin and low-dose vs high-dose aspirin","volume":"3","author":"Platt","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026020409520856600_ref11","doi-asserted-by":"publisher","first-page":"e253063","DOI":"10.1001\/jamanetworkopen.2025.3063","article-title":"Intravenous immunoglobulin alone for coronary artery lesion treatment of Kawasaki disease","volume":"8","author":"Kuo","year":"2025","journal-title":"JAMA Netw Open"},{"key":"2026020409520856600_ref12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jpids\/piae112","article-title":"Primary adjunctive corticosteroids in the acute Management of High-Risk Kawasaki Disease in a north American cohort","volume":"13","author":"Wang","year":"2024","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2026020409520856600_ref13","volume-title":"BCH Z-Score Calculator - about","author":"Colan","year":"2009"},{"key":"2026020409520856600_ref14","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(11)61930-2","article-title":"Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded-endpoints trial","volume":"379","author":"Kobayashi","year":"2012","journal-title":"Lancet."},{"key":"2026020409520856600_ref15","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation."},{"key":"2026020409520856600_ref16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0140-6736(84)91504-6","article-title":"High-dose intravenous gammaglobulin for Kawasaki disease","volume":"2","author":"Furusho","year":"1984","journal-title":"Lancet."},{"key":"2026020409520856600_ref17","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"2026020409520856600_ref18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1136\/archdischild-2018-314967","article-title":"Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease","volume":"104","author":"Cameron","year":"2019","journal-title":"Arch Dis Child"},{"key":"2026020409520856600_ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2024.03.010","article-title":"Different dose aspirin plus immunoglobulin (DAPI) for prevention of coronary artery abnormalities in Kawasaki disease: study protocol for a multi-center, prospective, randomized, open-label, blinded end-point, non-inferiority trial","volume":"273","author":"Wu","year":"2024","journal-title":"Am Heart J"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/advance-article-pdf\/doi\/10.1093\/jpids\/piag002\/66429214\/piag002.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/15\/2\/piag002\/66429214\/piag002.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/15\/2\/piag002\/66429214\/piag002.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:52:13Z","timestamp":1770216733000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/doi\/10.1093\/jpids\/piag002\/8427221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piag002","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,16]]},"article-number":"piag002"}}